Literature DB >> 11604997

Molecular cloning and characterization of human WNT3.

M Katoh1.   

Abstract

Mouse Wnt-3 is a proto-oncogene, which is activated by mouse mammary tumor virus (MMTV). Human WNT3 cDNA fragment, previously isolated by another group, corresponds to a partial coding sequence. WNT3 cDNA, spanning the complete coding sequence, was isolated in this study. WNT3 encoded 355-amino-acid polypeptide with the N-terminal signal peptide and two N-linked glycosylation sites. WNT3 was most homologous to WNT3A (84.2% total amino-acid identity) among human WNTs. The WNT3 gene on the human chromosome 17q21 region consisted of five exons. WNT3 mRNAs were detected in fetal brain, adult brain, and testis by Northern blot analyses. WNT3 mRNA was relatively highly expressed in A549 cells (lung cancer) and MKN45 cells (gastric cancer) among 37 human cancer cell lines. WNT3 was significantly up-regulated in a case of primary breast cancer and in a case of primary rectal cancer among various types of human primary cancers. These results strongly suggest that WNT3 might play a key role in some cases of human breast, rectal, lung, and gastric cancer through activation of the WNT - beta-catenin - TCF signaling pathway, similar to mouse Wnt-3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11604997     DOI: 10.3892/ijo.19.5.977

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  15 in total

1.  Sex-specific roles of beta-catenin in mouse gonadal development.

Authors:  Chia-Feng Liu; Nathan Bingham; Keith Parker; Humphrey H-C Yao
Journal:  Hum Mol Genet       Date:  2008-11-03       Impact factor: 6.150

2.  Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma.

Authors:  Pascal Gelebart; Mona Anand; Hanan Armanious; Anthea C Peters; Jennifer Dien Bard; Hesham M Amin; Raymond Lai
Journal:  Blood       Date:  2008-09-11       Impact factor: 22.113

3.  Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application.

Authors:  Blair Roszell; Mark J Mondrinos; Ariel Seaton; Donald M Simons; Sirma H Koutzaki; Guo-Hua Fong; Peter I Lelkes; Christine M Finck
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

4.  Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner.

Authors:  Bo Chen; Xiaoli Ma; Shifeng Liu; Weihong Zhao; Jianqing Wu
Journal:  Cancer Biol Ther       Date:  2012-08-24       Impact factor: 4.742

5.  Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.

Authors:  Miran Kim; Han Chu Lee; Orkhontuya Tsedensodnom; Rochelle Hartley; Young-Suk Lim; Eunsil Yu; Philippe Merle; Jack R Wands
Journal:  J Hepatol       Date:  2008-02-07       Impact factor: 25.083

6.  Aberrant Wnt/β-Catenin Signaling Pathway in Testis of Azoospermic Men​.

Authors:  Marefat Ghaffari Novin; Reza Mirfakhraie; Hamid Nazarian
Journal:  Adv Pharm Bull       Date:  2015-09-19

7.  Functional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells.

Authors:  S B Nambotin; Y Tomimaru; P Merle; J R Wands; M Kim
Journal:  Oncogenesis       Date:  2012-10-22       Impact factor: 7.485

8.  Physiopathological aspects of the Wnt/β-catenin signaling pathway in the male reproductive system.

Authors:  Ana Paola G Lombardi; Carine Royer; Raisa Pisolato; Fernanda N Cavalcanti; Thaís F G Lucas; Maria Fatima M Lazari; Catarina S Porto
Journal:  Spermatogenesis       Date:  2013-01-01

Review 9.  Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis.

Authors:  Masaru Katoh
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 6.692

10.  R-spondin 1/dickkopf-1/beta-catenin machinery is involved in testicular embryonic angiogenesis.

Authors:  Maria Caruso; Francesca Ferranti; Katia Corano Scheri; Gabriella Dobrowolny; Fabio Ciccarone; Paola Grammatico; Angela Catizone; Giulia Ricci
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.